Number of Metastatic Lymph Nodes in Resected Non-Small Cell Lung Cancer Predicts Patient Survival

Annals of Thoracic Surgery

Volumn 85, Issue 1, 2008, Pages 211-215

  Lee, Jin Gu ^a   Lee, Chang Young ^a   Park, In Kyu ^a   Kim, Dae Joon ^a   Park, Seong Yong ^a   Kim, Kil Dong ^b   Chung, Kyung Young ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Eulji University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DETERIORATION; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PATHOLOGICAL ANATOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 37249082467     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.08.020     Document Type: Article

References (21)

1. Mountain C.F. Revision of the international system for staging lung cancer. Chest 111 (1997) 1710-1717
2. Greene F.L., Page D.L., Fleming I.D., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York 99-106
3. Greene F.L., Page D.L., and Fleming I.D. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York 113-124
4. Greene F.L., Page D.L., and Fleming I.D. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York 171-180
5. Kodera Y., Yamamura Y., Shimizu Y., et al. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg 187 (1998) 597-603
6. Ichikura T., Tomimatsu S., Uefuji K., et al. Evaluation of the New American Joint Committee on Cancer/International Union Against Cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer 86 (1999) 553-558
7. Fukui T., Mori S., Yokoi K., and Mitsudomi T. Significance of the number of positive lymph nodes in resected non-small cell lung cancer. J Thorac Oncol 1 (2006) 120-125
8. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
9. Andre F., Grunenwald D., Pignon J.P., et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 18 (2000) 2981-2989
10. Ruckdeschel J.C. Combined modalities therapy of non-small cell lung cancer. Semin Oncol 24 (1997) 429-439
11. Osaki T., Nagashima A., Yoshimatsu T., Tashima Y., and Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 43 (2004) 151-157
12. Okada M., Sakamoto T., Yuki T., et al. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobed tumors. J Thorac Cardiovasc Surg 129 (2005) 825-830
13. Zielinski M., and Rami-Porta R. Proposals for changes in the Mountain and Dresler mediastinal and pulmonary lymph node map. J Thorac Oncol 2 (2007) 3-6
14. Compton C., Fielding L., Burgart L., et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 979-994
15. Tepper J., O'Connell M., Niedzwiecki D., et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19 (2001) 157-163
16. Herr H., Bochner B., Dalbagni G., Donat M., Reuter V., and Bajorin D. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167 (2002) 1295-1298
17. Herr H. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 61 (2003) 105-108
18. Polednak A. Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg 237 (2003) 163-167
19. Weir L., Speers C., D'yachkova Y., and Olivotto I. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 20 (2002) 1793-1799
20. Hermanek P. pTNM and residual tumor classification: problems of assessment and prognostic significance. World J Surg 19 (1995) 184-190
21. Ludwig M.S., Goodman M., Miller D.L., and Johnstone P.A. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 128 (2005) 1545-1550